UNH vs. HUM: Which Insurance Stock Offers Greater Potential Following CMS's Reversal of Wall Street's Major Medicare Rate Concern?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Source: stocktwits
Medicare Advantage Funding Increase: A revised policy is set to add over $13 billion in funding to Medicare Advantage plans, following a previous proposal that significantly impacted insurers' market value.
Stock Performance: Shares of UnitedHealth (UNH) rose by 8% and Humana (HUM) gained 11% after the announcement, although both stocks have seen declines of approximately 45% and 27% respectively over the past year.
Payment Rate Adjustments: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% increase in Medicare Advantage payment rates for 2027, reversing earlier proposals that kept rates flat.
Market Sentiment: Retail sentiment for UNH and HUM remains bullish, with analysts providing a range of ratings, indicating a strong outlook for UnitedHealth's expanding AI strategy and potential revenue relief amidst rising medical costs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 382.480
Low
330.00
Averages
397.82
High
444.00
Current: 382.480
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Greg Abel's First Quarter Report Reveals Investment Strategy
- Portfolio Adjustments: In his first quarterly report, Abel adjusted the $330 billion equity portfolio by adding positions in Delta Airlines and Macy's, while tripling the stake in Alphabet, indicating his proactive approach to high-conviction stocks while maintaining Buffett's investment style.
- Small Position Sell-Off: In the first quarter, Abel and his team sold out of 16 smaller positions, including Visa and Mastercard, which accounted for about a third of Berkshire's total holdings, demonstrating decisive action in optimizing the investment portfolio.
- Core Holdings Retained: Despite the significant sell-off, Abel retained core holdings such as Apple, American Express, and Coca-Cola, reflecting his respect for and continuation of the company's traditional investment strategies established by Buffett.
- Positive Market Reaction: Following the announcement of Abel's investment strategy, Berkshire Hathaway's stock ticked higher, reflecting market confidence in his management capabilities and further solidifying the company's position in the investment community.
See More
Berkshire Hathaway's Abel Restructures Equity Portfolio
- Portfolio Restructuring: Greg Abel cut 16 small positions in the first quarter, including long-held Visa and Mastercard, demonstrating a strategic focus on concentrated high-conviction stocks while maintaining Buffett's traditional investment style.
- New Investment Directions: Abel added positions in Delta Airlines and Macy's, and tripled the investment in Alphabet, indicating a strategy aligned with Buffett's tech stock preferences, which may attract younger investors.
- Increased Concentration: Excluding investments in Japan, Berkshire now holds only 29 positions, retaining Buffett favorites like Apple, American Express, and Coca-Cola, reflecting ongoing confidence in classic quality assets.
- Positive Market Reaction: Despite the reduction of about one-third of the portfolio, Berkshire's stock price rose following the announcement, indicating market approval of Abel's investment strategy and suggesting optimistic expectations for future performance.
See More
Healthcare Stocks Surge Due to Innovation and Policy Changes
- Strong Sector Performance: The healthcare sector has shown remarkable performance, with the State Street Health Care Select Sector SPDR ETF (XLV) rising 3.3% over the past week, significantly outperforming the S&P 500's 0.5% gain, indicating a robust rebound and renewed investor confidence in healthcare stocks.
- Drug Innovation Driving Prices: Merck (MRK) saw a substantial stock price increase after announcing a lung cancer drug that reduced tumor progression risk by 65% in a Phase 3 study, highlighting the positive impact of ongoing pharmaceutical innovation on stock valuations.
- Favorable Medicare Policies: The Centers for Medicare and Medicaid Services announced that starting in 2027, Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month, resulting in a 25% stock price increase for Lilly over three weeks, demonstrating the direct support of policy changes for healthcare stocks.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals, medical devices, and health insurance, positioning the healthcare sector as a focal point for investors seeking growth opportunities in the face of demographic shifts.
See More
Healthcare Sector Sees Best Week in Six Months
- Strong Sector Performance: The State Street Health Care Select Sector SPDR ETF (XLV) rose 3.3% over the past five trading days, significantly outperforming the S&P 500's 0.5% gain, establishing healthcare as the top-performing sector this week and reflecting strong investor confidence in the industry.
- Pharmaceutical Innovation: Merck (MRK) saw its stock rise 5.63% this week after announcing a 65% reduction in tumor progression risk from a lung cancer drug developed with a Chinese partner in a Phase 3 study, highlighting the ongoing innovation within the pharmaceutical sector.
- Favorable Insurance Policies: The Centers for Medicare and Medicaid Services announced that Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month starting January 2027, leading to a 25% stock price increase for Lilly over three weeks, showcasing the positive impact of policy changes on company performance.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals and medical services, positioning the healthcare sector for robust growth and attracting investors to healthcare ETFs as a safer investment choice amid economic uncertainties.
See More
UnitedHealth Group's AI Technology Fuels Stock Recovery
- AI Chatbot Launch: UnitedHealth Group introduced a generative AI chatbot named Avery in March, designed to coordinate healthcare experiences for members, currently serving 6.5 million employer-sponsored plan members, with plans to expand to over 20 million by year-end, significantly enhancing customer satisfaction and service efficiency.
- Strong Stock Recovery: Since the announcement of the Avery system, UnitedHealth's stock has surged 53% over the past two months, reflecting positive market sentiment towards its AI adoption and bolstered by the company's first-quarter financial results that exceeded Wall Street expectations.
- Reduced Medical Benefit Ratio: The company reported a decrease in its medical benefit ratio to 83.9%, down from 84.8% a year ago and below the 85.5% expected by analysts, indicating significant progress in reducing operational costs and improving profitability through the application of AI tools.
- Future Investment Plans: UnitedHealth plans to invest an additional $1.6 billion in AI technology this year, aiming to further streamline healthcare processes and reduce administrative waste, a strategy that will provide greater growth potential in the competitive health insurance market.
See More
UnitedHealth Group's Strong Rebound in 2026 Driven by AI
- AI-Driven Recovery: UnitedHealth Group has rebounded sharply in 2026, partly due to the implementation of AI, particularly its generative AI chatbot named Avery, which currently serves 6.5 million members and is expected to expand to over 20 million by year-end, enhancing customer experience and operational efficiency.
- Market Share Advantage: As the largest health insurer in the U.S., UnitedHealth dominates Medicare Advantage coverage in 41% of 3,200 counties, with approximately 45 million members, creating a substantial demand for data processing that makes AI applications crucial for maintaining its market leadership.
- Strong Financial Performance: The company exceeded Wall Street expectations in Q1 2026 with revenue and earnings, raising its earnings guidance from $17.75 to $18.25 per share, while reducing its medical benefit ratio to 83.9%, below the industry expectation of 85.5%, demonstrating AI's effectiveness in cost reduction.
- Policy Support: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, amounting to about $13 billion, significantly surpasses the initial estimate of 0.09%, providing additional support for UnitedHealth's future growth and boosting investor confidence.
See More
Greg Abel's First Quarter Report Reveals Investment Strategy
- Portfolio Adjustments: In his first quarterly report, Abel adjusted the $330 billion equity portfolio by adding positions in Delta Airlines and Macy's, while tripling the stake in Alphabet, indicating his proactive approach to high-conviction stocks while maintaining Buffett's investment style.
- Small Position Sell-Off: In the first quarter, Abel and his team sold out of 16 smaller positions, including Visa and Mastercard, which accounted for about a third of Berkshire's total holdings, demonstrating decisive action in optimizing the investment portfolio.
- Core Holdings Retained: Despite the significant sell-off, Abel retained core holdings such as Apple, American Express, and Coca-Cola, reflecting his respect for and continuation of the company's traditional investment strategies established by Buffett.
- Positive Market Reaction: Following the announcement of Abel's investment strategy, Berkshire Hathaway's stock ticked higher, reflecting market confidence in his management capabilities and further solidifying the company's position in the investment community.
See More
Berkshire Hathaway's Abel Restructures Equity Portfolio
- Portfolio Restructuring: Greg Abel cut 16 small positions in the first quarter, including long-held Visa and Mastercard, demonstrating a strategic focus on concentrated high-conviction stocks while maintaining Buffett's traditional investment style.
- New Investment Directions: Abel added positions in Delta Airlines and Macy's, and tripled the investment in Alphabet, indicating a strategy aligned with Buffett's tech stock preferences, which may attract younger investors.
- Increased Concentration: Excluding investments in Japan, Berkshire now holds only 29 positions, retaining Buffett favorites like Apple, American Express, and Coca-Cola, reflecting ongoing confidence in classic quality assets.
- Positive Market Reaction: Despite the reduction of about one-third of the portfolio, Berkshire's stock price rose following the announcement, indicating market approval of Abel's investment strategy and suggesting optimistic expectations for future performance.
See More
Healthcare Stocks Surge Due to Innovation and Policy Changes
- Strong Sector Performance: The healthcare sector has shown remarkable performance, with the State Street Health Care Select Sector SPDR ETF (XLV) rising 3.3% over the past week, significantly outperforming the S&P 500's 0.5% gain, indicating a robust rebound and renewed investor confidence in healthcare stocks.
- Drug Innovation Driving Prices: Merck (MRK) saw a substantial stock price increase after announcing a lung cancer drug that reduced tumor progression risk by 65% in a Phase 3 study, highlighting the positive impact of ongoing pharmaceutical innovation on stock valuations.
- Favorable Medicare Policies: The Centers for Medicare and Medicaid Services announced that starting in 2027, Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month, resulting in a 25% stock price increase for Lilly over three weeks, demonstrating the direct support of policy changes for healthcare stocks.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals, medical devices, and health insurance, positioning the healthcare sector as a focal point for investors seeking growth opportunities in the face of demographic shifts.
See More
Healthcare Sector Sees Best Week in Six Months
- Strong Sector Performance: The State Street Health Care Select Sector SPDR ETF (XLV) rose 3.3% over the past five trading days, significantly outperforming the S&P 500's 0.5% gain, establishing healthcare as the top-performing sector this week and reflecting strong investor confidence in the industry.
- Pharmaceutical Innovation: Merck (MRK) saw its stock rise 5.63% this week after announcing a 65% reduction in tumor progression risk from a lung cancer drug developed with a Chinese partner in a Phase 3 study, highlighting the ongoing innovation within the pharmaceutical sector.
- Favorable Insurance Policies: The Centers for Medicare and Medicaid Services announced that Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month starting January 2027, leading to a 25% stock price increase for Lilly over three weeks, showcasing the positive impact of policy changes on company performance.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals and medical services, positioning the healthcare sector for robust growth and attracting investors to healthcare ETFs as a safer investment choice amid economic uncertainties.
See More
UnitedHealth Group's AI Technology Fuels Stock Recovery
- AI Chatbot Launch: UnitedHealth Group introduced a generative AI chatbot named Avery in March, designed to coordinate healthcare experiences for members, currently serving 6.5 million employer-sponsored plan members, with plans to expand to over 20 million by year-end, significantly enhancing customer satisfaction and service efficiency.
- Strong Stock Recovery: Since the announcement of the Avery system, UnitedHealth's stock has surged 53% over the past two months, reflecting positive market sentiment towards its AI adoption and bolstered by the company's first-quarter financial results that exceeded Wall Street expectations.
- Reduced Medical Benefit Ratio: The company reported a decrease in its medical benefit ratio to 83.9%, down from 84.8% a year ago and below the 85.5% expected by analysts, indicating significant progress in reducing operational costs and improving profitability through the application of AI tools.
- Future Investment Plans: UnitedHealth plans to invest an additional $1.6 billion in AI technology this year, aiming to further streamline healthcare processes and reduce administrative waste, a strategy that will provide greater growth potential in the competitive health insurance market.
See More
UnitedHealth Group's Strong Rebound in 2026 Driven by AI
- AI-Driven Recovery: UnitedHealth Group has rebounded sharply in 2026, partly due to the implementation of AI, particularly its generative AI chatbot named Avery, which currently serves 6.5 million members and is expected to expand to over 20 million by year-end, enhancing customer experience and operational efficiency.
- Market Share Advantage: As the largest health insurer in the U.S., UnitedHealth dominates Medicare Advantage coverage in 41% of 3,200 counties, with approximately 45 million members, creating a substantial demand for data processing that makes AI applications crucial for maintaining its market leadership.
- Strong Financial Performance: The company exceeded Wall Street expectations in Q1 2026 with revenue and earnings, raising its earnings guidance from $17.75 to $18.25 per share, while reducing its medical benefit ratio to 83.9%, below the industry expectation of 85.5%, demonstrating AI's effectiveness in cost reduction.
- Policy Support: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, amounting to about $13 billion, significantly surpasses the initial estimate of 0.09%, providing additional support for UnitedHealth's future growth and boosting investor confidence.
See More
